Retinoblastoma

Livia Lumbroso-Le Rouic1

  • 1Institut Curie, service d'ophtalmologie, Paris, France.

La Revue Du Praticien
|December 5, 2018
PubMed

Insights

Retinoblastoma is a rare childhood eye cancer caused by RB1 gene mutations. While survival is high in developed nations, disparities persist globally, impacting visual outcomes.

Area of Science:

  • Ophthalmology
  • Pediatric Oncology
  • Genetics

Background:

  • Retinoblastoma is the most common malignant intraocular tumor in children.
  • It is a rare genetic disease resulting from RB1 gene mutations.
  • Significant survival disparities exist between developed and developing countries.

Purpose of the Study:

  • To summarize the key aspects of retinoblastoma.
  • To highlight the importance of early detection and treatment.
  • To discuss factors influencing visual prognosis.

Main Methods:

  • Literature review of retinoblastoma epidemiology, genetics, and clinical presentation.
  • Analysis of survival rates and visual outcomes based on geographical location.
  • Emphasis on diagnostic signs and recommended examinations.

Main Results:

  • High survival rates (98%) are achievable in developed countries.
  • Lower survival rates are observed in developing regions, with mortality still occurring.
  • Tumor characteristics and conservative treatment impact visual prognosis.

Conclusions:

  • Early detection of retinoblastoma, particularly leukocoria, is crucial.
  • Prompt fundus examination is essential for suspected cases.
  • Addressing global disparities in care is vital for improving outcomes.